News

The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus vaccine. The United States is still waiting for a return on its investment—and the 110...

Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of Prescription Medication Promotion is watching the drug, which combines two common cholesterol therapies into one...

Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility, along with the recent FDA approval of its new prefilled syringe line, puts Seqirus in...

The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a novel class of broad-spectrum antibiotic compounds focused on treating serious illnesses caused by multi drug resistant bacteria. Bugworks is now...

The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and eliminates its consumer unit. GSK has utilised the orange colour in its logo for a...

Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the National Institute for Health and Care Excellence (NICE), the United Kingdom's pricing watchdog, for around 425,000 people with high...

Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the tardive dyskinesia drug Austedo for growth. Teva has settled its patent infringement action with Aurobindo...